Skip to content
DataLookout
Menu

H. Lee Moffitt Cancer Center and Research Institute clinical trial pipeline

Get alerts when H. Lee Moffitt Cancer Center and Research Institute's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area Trial completed H. Lee Moffitt Cancer Center and Research InstituteNot applicable NCT07218848
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-17 NCT07940738 Ph 1 Study Long-acting Interleukin-7, Efineptakin Alfa, to Enhance Immune Reconstitution… Phase 1 Recruiting
2026-11-16 NCT07937423 DYNAMIC Pilot Optimization Trial Not Yet Recruiting
2026-11-10 NCT07930182 Adjuvant/Neoadjuvant Immunotherapy in Melanoma Based on Serial Plasma ctDNA Monitoring Phase 2 Recruiting

Active trials by phase

Early Phase 1
7
Phase 1
25
Phase 1/2
9
Phase 2
55
Phase 2/3
1
Phase 3
1
Not charted: 41 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 33

Get alerts when H. Lee Moffitt Cancer Center and Research Institute's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free